Conti, M.; Bolzacchini, E.; Luchena, G.; Bertu’, L.; Tagliabue, P.; Aglione, S.; Ardizzoia, A.; Arnoffi, J.; Guida, F.M.; Bertolini, A.;
et al. Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study. Cancers 2023, 15, 3465.
https://doi.org/10.3390/cancers15133465
AMA Style
Conti M, Bolzacchini E, Luchena G, Bertu’ L, Tagliabue P, Aglione S, Ardizzoia A, Arnoffi J, Guida FM, Bertolini A,
et al. Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study. Cancers. 2023; 15(13):3465.
https://doi.org/10.3390/cancers15133465
Chicago/Turabian Style
Conti, Matteo, Elena Bolzacchini, Giovanna Luchena, Lorenza Bertu’, Paola Tagliabue, Stefania Aglione, Antonio Ardizzoia, Jessica Arnoffi, Francesco Maria Guida, Alessandro Bertolini,
and et al. 2023. "Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study" Cancers 15, no. 13: 3465.
https://doi.org/10.3390/cancers15133465
APA Style
Conti, M., Bolzacchini, E., Luchena, G., Bertu’, L., Tagliabue, P., Aglione, S., Ardizzoia, A., Arnoffi, J., Guida, F. M., Bertolini, A., Pastorini, A., Duro, M., Bettega, D., Roda’, G., Artale, S., Squizzato, A., & Giordano, M.
(2023). Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study. Cancers, 15(13), 3465.
https://doi.org/10.3390/cancers15133465